Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 23:9:33.
doi: 10.1186/s13033-015-0026-6. eCollection 2015.

Delayed identification and diagnosis of Huntington's disease due to psychiatric symptoms

Affiliations

Delayed identification and diagnosis of Huntington's disease due to psychiatric symptoms

Alina Mihaela Pascu et al. Int J Ment Health Syst. .

Abstract

Huntington's disease (HD) is a progressive neurodegenerative illness that affects 2-9/100.000 of the general population. The usual onset is at around age 35-40 years, but there were cases with onset above 55 years. The disease manifests clinically with many neurological and psychiatric symptoms, leading in advanced phases to dementia, but cognitive symptoms are frequently present much earlier in the disease course. HD is caused by an expanded polyglutamine stretch in the N-terminal part of a 350 kDa protein called huntingtin (HTT). This stretch is encoded by a trinucleotide CAG repetition in exon 1 of HTT. An expansion of greater than 36 repeats results in HD. The number of repeats is inversely correlated with the age of onset of motor symptoms, and disease onset during childhood or adolescence is associated with more than 60 CAG repeats. Mood disturbances may be one of the earliest symptoms of HD and may precede the onset of the motor pheno-type for almost 10 years. Neuropsychiatric symptoms may delay the appropriate diagnosis of HD and have major implications for disease management, prognosis and quality of life for patients and families. This case study is about a 58 years old female patient with late identification of Huntington's disease after two admissions to psychiatric inpatient units, for the treatment of behavioral disturbances.

PubMed Disclaimer

References

    1. Gusella JF, Mac Donald ME. Huntington’s disease: the case for genetic modifiers. Genome Med. 2009;1(8):80. doi: 10.1186/gm80. - DOI - PMC - PubMed
    1. Novak MJ, Tabrizi SJ. Huntington’s disease: clinical presentation and treatment. Int Rev Neurobiol. 2011;98:297–323. doi: 10.1016/B978-0-12-381328-2.00013-4. - DOI - PubMed
    1. Paulsen JS. Cognitive impairment in huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep. 2011;11:474–483. doi: 10.1007/s11910-011-0215-x. - DOI - PMC - PubMed
    1. Huntington Collaborative Research Group A novel gene containing a trin- ucleotide that is expanded and unstable on huntington’s disease chromosomes. Cell. 1993;72:971–983. doi: 10.1016/0092-8674(93)90585-E. - DOI - PubMed
    1. Walker FO. Huntington’s disease. Lancet. 2007;369:218–228. doi: 10.1016/S0140-6736(07)60111-1. - DOI - PubMed

LinkOut - more resources